Form 15-12G - Securities registration termination [Section 12(g)]
13 Agosto 2024 - 5:46AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-31938
ACORDA THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
2 Blue Hill
Plaza, 3rd Floor, Pearl River, New York
(914) 347-4300
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock $0.001 par value per share
(Title of each class of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an
X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
Rule 12g-4(a)(1) |
|
☒ |
Rule 12g-4(a)(2) |
|
☐ |
Rule 12h-3(b)(1)(i) |
|
☒ |
Rule 12h-3(b)(1)(ii) |
|
☐ |
Rule 15d-6 |
|
☐ |
Rule 15d-22(b) |
|
☐ |
Approximate number of holders of record as of the certification or notice date: 90
Pursuant to the requirements of the Securities Exchange Act of 1934, Acorda Therapeutics,
Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
Date: August 13, 2024 |
|
|
|
By: |
|
/s/ Michael A. Gesser |
|
|
|
|
Name: |
|
Michael A. Gesser |
|
|
|
|
Title: |
|
Chief Financial Officer and Treasurer |
Acorda Therapeutics (PK) (USOTC:ACORQ)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024
Acorda Therapeutics (PK) (USOTC:ACORQ)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024
Real-Time news about Acorda Therapeutics Inc (PK) (OTCMarkets): 0 recent articles
Más de Acorda Therapeutics Inc (PK) Artículos de Noticias